QUECTEL-WIRELESS
14.3.2023 09:02:03 CET | Business Wire | Press release
Quectel Wireless Solutions, a global IoT solutions provider, today announces how its latest smart module with machine compute and edge intelligence capabilities is revolutionizing the color sorter industry with higher efficiency and accuracy. Employing Quectel’s high performance SG560D smart module, the solution improves the color sorting of industrial materials that can be transformed via a visual identification system, through a combination of machine vision and edge intelligence capabilities, and automatically sort objects based on color and shapes accordingly.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314005130/en/
Quectel showcases industrial smart color sorter solution with edge intelligence at Embedded World 2023
The advanced color sorter application, aimed at the industrial materials management industry, utilizes the Quectel SG560D smart module based on the Qualcomm QCS6490 chipset, and additional integrated hardware including cameras, lamps, and air guns. The solution is able to detect, recognize, and sort a broad array of textures, colors and materials including food materials such as rice, wheat, corn, soybean, seeds, nuts, salt, plastic objects such as plastic pieces, plastic granules, plastic bottle cap flake as well as minerals like quartz stone, quartz sand, pearls, marble, and others.
“As a global leader, Quectel is committed to serving our customers across all industries with the latest innovative technologies. We are proud to drive innovations in large industrial verticals such as color sorting where machine vision, edge computing and next-generation robotics applications can transform entire industries with faster time-to-market, increase productivity and produce significant cost-savings,” said Norbert Muhrer, President and CSO, Quectel Wireless Solutions.
With advanced visual identification system, the smart color sorter solution can manage color sorting of high-volume objects with four cameras working simultaneously to stream video, with an accuracy of less than 1/200000 error rate. Additionally, it can help reduce operating and labor expense significantly.
Quectel’s SG560D is a powerful smart module equipped with a Qualcomm® Kryo™ 670 CPU built on Arm v8 Cortex technology and a Qualcomm® Adreno™ 642L GPU. It also features 2 x HVX high-performance digital signal processing (DSP), which bring superior computing power to enable fast, high-quality data processing and make quicker, data-driven decisions. Tests indicate that the SG560D module can achieve computing performance of up to 14 trillion operations per second (TOPS).
The SG560D also supports 5G new radio (NR), Wi-Fi 6E bands of 2.4 GHz, 5 GHz and 6 GHz, dual-band simultaneous (DBS), Wi-Fi 2x2 MU-MIMO and Bluetooth 5.2, which significantly improves network coverage and enhances transmission data rates in different application scenarios.
To learn more, visit the Quectel booth at Embedded World 2023, Hall 3, Booth 318 where we will be demonstrating Quectel’s smart module solutions with machine vision and edge capabilities.
About Quectel
Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services.
Our growing global team of over 4,000 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules, antennas and IoT connectivity.
With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.
For more information: www.quectel.com, LinkedIn, Facebook, and Twitter.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230314005130/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom